FDA Hearing On Stem Cell Drugs With BioTech Companies FDA的聽證會幹細胞藥物與生物技術公司
The Food and Drug Administration (USA) has decided to go for a two day hearing with the biotech companies over the issue to approve clinical trials for the first generation of stem cell derived drugs.美國食品和藥物管理局(美國)已決定去進行為期兩天的聽證會,與生物技術公司在該問題上批准臨床試驗,為第一代的幹細胞衍生的藥物。 The biotech industry wants FDA guidelines for the complex approval process and very much expects its opinion to be free from political influence.生物技術產業要FDA的指導方針,為複雜的審批程序,並十分期待其意見,以免受政治影響力。
































